Candidiasis, Invasive Completed Phase 4 Trials for Voriconazole (DB00582)

Also known as: Invasive Candidiasis / Systemic moniliasis / Systemic candida / Disseminated candidiasis / Disseminated candida / Systemic candidiasis

IndicationStatusPhase
DBCOND0036184 (Candidiasis, Invasive)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00548262This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive CandidiasisTreatment